16alpha-methyl or ethyl substituted estrogens

Details for Australian Patent Application No. 2001282016 (hide)

Owner Akzo Nobel N.V.

Inventors Loozen, Hubert Jan Jozef; Mestres, Jordi; Veeneman, Gerrit Herman

Agent Spruson & Ferguson

Pub. Number AU-B-2001282016

PCT Pub. Number WO02/10188

Priority 00202697 28.07.00 EP

Filing date 23 July 2001

Wipo publication date 13 February 2002

Acceptance publication date 10 November 2005

International Classifications

C07J 001/00 Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing carbon, hydrogen, halogen, or oxygen

C07J 071/00 Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring

A61P 005/30 Drugs for disorders of the endocrine system

A61K 031/565 - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

C07J 051/00 Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups

Event Publications

10 November 2005 Application Accepted

  Published as AU-B-2001282016

9 March 2006 Standard Patent Sealed

9 November 2006 Assignment Registered

  Akzo Nobel N.V. The patent has been assigned to N.V. Organon

18 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001282017-Sensor chips with multi-layers of polysiloxane

2001282015